Jeremy Bender, Chief Executive Officer at Day One Biopharmaceuticals, Inc. (DAWN), sold 8,006 shares at $24.31 ($195K) on 2022-08-16, disclosed to the SEC on 2022-08-17.
Open-market sale of $195k DAWN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.31 | 4,003 | $97K | 50.0% |
| 2 | $24.31 | 4,003 | $97K | 50.0% |
| Total | $24.31 avg | 8,006 | $195K | 100% |
| Filing → |
| DAWN | SELL | 2025-08-19 | $217K | — | Filing → |
| DAWN | SELL | 2025-05-19 | $175K | — | Filing → |
| DAWN | SELL | 2025-02-21 | $288K | — | Filing → |